Laboratory controls do not include scientifically sound and appropriate specifications, sampling plans and test procedures designed to assure that raw materials conform to established standards of quality and/or purity.
Inspection Record
Qingdao Kangyuan Pharmaceutical Co., LTD — FDA 483 Findings
Inspectors Alan A. Rivera · Chad RiceThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Failure to validate and verify the suitability of analytical methods.
The master batch production record lacks an established time limit and detailed production instructions to ensure the quality of intermediates and APIs are met for individual processing steps and/or total process.
A record as of the US FDA document published on 2026-11-13. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.